Inovio Pharmaceuticals, Inc.NASDAQ: INO

INOVIO to Report Second Quarter Financial Results on August 12, 2026

· Issued by Inovio Pharmaceuticals, Inc. via PR Newswire

Summary by 6ix AI

INOVIO, a biotechnology company developing DNA medicines for HPV-related diseases, cancer and infectious diseases, will release its second quarter 2026 financial results after the market close on August 12, 2026.

Key details

  • INOVIO will host a live conference call and webcast at 4:30 p.m. ET on the same day to discuss the results and give a general business update.
  • The webcast is listen-only but will include a live question-and-answer session with analysts, and will be archived for replay for 90 days after the event.

6ix AI wrote this summary from the release below and checked it against the release.

PLYMOUTH MEETING, Pa., Aug. 4, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that its second quarter 2026 financial results will be released after the market close on August 12th, 2026. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss the financial results and provide a general business update.

The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing innovative DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com

Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505, investor.relations@inovio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-second-quarter-financial-results-on-august-12-2026-302842917.html

SOURCE INOVIO Pharmaceuticals, Inc.

View original source (PR Newswire)Inovio Pharmaceuticals, Inc. on 6ix

Story so far

Earlier from Inovio Pharmaceuticals

Later from Inovio Pharmaceuticals

All Inovio Pharmaceuticals news releases